Complications of Treatment in Youth with HIV.

Author Information (click to view)

Eckard AR, Fowler SL, Haston JC, Dixon TC,

Eckard AR, Fowler SL, Haston JC, Dixon TC, (click to view)

Eckard AR, Fowler SL, Haston JC, Dixon TC,

Share on FacebookTweet about this on TwitterShare on LinkedIn

Current HIV/AIDS reports 2016 5 27()


While combination antiretroviral therapy allows HIV-infected patients to have life expectancies similar to that of the general population, it may also contribute to the development of co-morbidities, such as cardiovascular disease and osteoporosis. Such complications could compromise long-term quality of life, especially in HIV-infected youth whose lifetime cumulative exposure to antiretrovirals is likely to be many decades. Recent studies continue to demonstrate abnormalities associated with antiretroviral therapy, although clinical manifestations are rare in this younger population, especially with modern antiretrovirals. The purpose of this paper is to review the most recent literature on complications of treatment in youth with HIV.

Submit a Comment

Your email address will not be published. Required fields are marked *

nineteen − twelve =